Ischemia reperfusion induces IFN regulatory factor 4 in renal dendritic cells, which suppresses postischemic inflammation and prevents acute renal failure

Journal of Immunology

Volumn 185, Issue 3, 2010, Pages 1976-1983

  Lassen, Saraswati ^a   Lech, Maciej ^a   Römmele, Christoph ^a   Mittruecker, Hans Willi ^b,c   Mak, Tak W ^c   Anders, Hans Joachim ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^c PRINCESS MARGARET HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CD45 ANTIGEN; CLODRONIC ACID; CXCL2 CHEMOKINE; ETANERCEPT; GLYCOPROTEIN P 15095; INTERFERON REGULATORY FACTOR 4; INTERLEUKIN 6; LIPOSOME; MONOCYTE CHEMOTACTIC PROTEIN 1; TUMOR NECROSIS FACTOR ALPHA; INTERFERON REGULATORY FACTOR; INTERFERON REGULATORY FACTOR-4;

ACUTE KIDNEY FAILURE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY CLAMP; ARTICLE; BONE MARROW CELL; CONTROLLED STUDY; DENDRITIC CELL; KIDNEY CELL; KIDNEY ISCHEMIA; KIDNEY TUBULE NECROSIS; LOSS OF FUNCTION MUTATION; MOUSE; NEPHRITIS; NEUTROPHIL; NONHUMAN; NUCLEOTIDE SEQUENCE; OXIDATIVE STRESS; PRIORITY JOURNAL; RENAL ARTERY; ANIMAL; ANTIGEN PRESENTING CELL; BIOSYNTHESIS; C57BL MOUSE; IMMUNOLOGY; INFLAMMATION; INNATE IMMUNITY; KIDNEY; MALE; METABOLISM; MOUSE MUTANT; PATHOLOGY; PHYSIOLOGY; REPERFUSION INJURY;

ANIMALS; ANTIGEN-PRESENTING CELLS; ANTIGENS, CD11C; ANTIGENS, CD45; DENDRITIC CELLS; IMMUNITY, INNATE; INFLAMMATION; INTERFERON REGULATORY FACTORS; KIDNEY; KIDNEY FAILURE, ACUTE; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; REPERFUSION INJURY;

EID: 77956399102     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.0904207     Document Type: Article

References (46)

1. Bonventre, J. V., and A. Zuk. 2004. Ischemic acute renal failure: an inflammatory disease? Kidney Int. 66: 480-485.
2. Medzhitov, R., P. Preston-Hurlburt, and C. A. Janeway, Jr. 1997. A human homologue of the Drosophila Toll protein signals activation of adaptive immunity. Nature 388: 394-397.
3. Tsuboi, N., Y. Yoshikai, S. Matsuo, T. Kikuchi, K. Iwami, Y. Nagai, O. Takeuchi, S. Akira, and T. Matsuguchi. 2002. Roles of toll-like receptors in C-C chemokine production by renal tubular epithelial cells. J. Immunol. 169: 2026-2033. (Pubitemid 34857667)
4. Akira, S., S. Uematsu, and O. Takeuchi. 2006. Pathogen recognition and innate immunity. Cell 124: 783-801.
5. Patole, P. S., S. Schubert, K. Hildinger, S. Khandoga, A. Khandoga, S. Segerer, A. Henger, M. Kretzler, M. Werner, F. Krombach, et al. 2005. Toll-like receptor-4: renal cells and bone marrow cells signal for neutrophil recruitment during pyelonephritis. Kidney Int. 68: 2582-2587.
6. Yang, C. W., C. C. Hung, M. S. Wu, Y. C. Tian, C. T. Chang, M. J. Pan, and A. Vandewalle. 2006. Toll-like receptor 2 mediates early inflammation by leptospiral outer membrane proteins in proximal tubule cells. Kidney Int. 69: 815-822.
7. Kono, H., and K. L. Rock. 2008. How dying cells alert the immune system to danger. Nat. Rev. Immunol. 8: 279-289.
8. Medzhitov, R. 2008. Origin and physiological roles of inflammation. Nature 454: 428-435.
9. Leemans, J. C., G. Stokman, N. Claessen, K. M. Rouschop, G. J. Teske, C. J. Kirschning, S. Akira, T. van der Poll, J. J. Weening, and S. Florquin. 2005. Renal-associated TLR2 mediates ischemia/reperfusion injury in the kidney. J. Clin. Invest. 115: 2894-2903.
10. Wu, H., G. Chen, K. R. Wyburn, J. Yin, P. Bertolino, J. M. Eris, S. I. Alexander, A. F. Sharland, and S. J. Chadban. 2007. TLR4 activation mediates kidney ischemia/reperfusion injury. J. Clin. Invest. 117: 2847-2859.
11. Shigeoka, A. A., T. D. Holscher, A. J. King, F. W. Hall, W. B. Kiosses, P. S. Tobias, N. Mackman, and D. B. McKay. 2007. TLR2 is constitutively expressed within the kidney and participates in ischemic renal injury through both MyD88-dependent and -independent pathways. J. Immunol. 178: 6252-6258.
12. Zhai, Y., X. D. Shen, R. O'Connell, F. Gao, C. Lassman, R. W. Busuttil, G. Cheng, and J. W. Kupiec-Weglinski. 2004. Cutting edge: TLR4 activation mediates liver ischemia/reperfusion inflammatory response via IFN regulatory factor 3-dependent MyD88-independent pathway. J. Immunol. 173: 7115-7119.
13. Oyama, J., C. Blais, Jr., X. Liu, M. Pu, L. Kobzik, R. A. Kelly, and T. Bourcier. 2004. Reduced myocardial ischemia-reperfusion injury in toll-like receptor 4-deficient mice. Circulation 109: 784-789. (Pubitemid 38222900)
14. Shishido, T., N. Nozaki, S. Yamaguchi, Y. Shibata, J. Nitobe, T. Miyamoto, H. Takahashi, T. Arimoto, K. Maeda, M. Yamakawa, et al. 2003. Toll-like receptor-2 modulates ventricular remodeling after myocardial infarction. Circulation 108: 2905-2910. (Pubitemid 37517819)
15. Tang, S. C., T. V. Arumugam, X. Xu, A. Cheng, M. R. Mughal, D. G. Jo, J. D. Lathia, D. A. Siler, S. Chigurupati, X. Ouyang, et al. 2007. Pivotal role for neuronal Toll-like receptors in ischemic brain injury and functional deficits. Proc. Natl. Acad. Sci. USA 104: 13798-13803.
16. Nelson, P. J. 2007. Renal ischemia-reperfusion injury: renal dendritic cells loudly sound the alarm. Kidney Int. 71: 604-605. (Pubitemid 46494563)
17. O'Neill, L. A. 2008. When signaling pathways collide: positive and negative regulation of toll-like receptor signal transduction. Immunity 29: 12-20.
18. Wald, D., J. Qin, Z. Zhao, Y. Qian, M. Naramura, L. Tian, J. Towne, J. E. Sims, G. R. Stark, and X. Li. 2003. SIGIRR, a negative regulator of Toll-like receptor-interleukin 1 receptor signaling. Nat. Immunol. 4: 920-927.
19. Polentarutti, N., G. P. Rol, M. Muzio, D. Bosisio, M. Camnasio, F. Riva, C. Zoja, A. Benigni, S. Tomasoni, A. Vecchi, et al. 2003. Unique pattern of expression and inhibition of IL-1 signaling by the IL-1 receptor family member TIR8/SIGIRR. Eur. Cytokine Netw. 14: 211-218.
20. Qin, J., Y. Qian, J. Yao, C. Grace, and X. Li. 2005. SIGIRR inhibits interleukin-1 receptor- and toll-like receptor 4-mediated signaling through different mechanisms. J. Biol. Chem. 280: 25233-25241.
21. Lech, M., C. Garlanda, A. Mantovani, C. J. Kirschning, D. Schlöndorff, and H. J. Anders. 2007. Different roles of TiR8/Sigirr on toll-like receptor signaling in intrarenal antigen-presenting cells and tubular epithelial cells. Kidney Int. 72: 182-192.
22. Lech, M., A. Avila-Ferrufino, R. Allam, S. Segerer, A. Khandoga, F. Krombach, C. Garlanda, A. Mantovani, and H. J. Anders. 2009. Resident dendritic cells prevent postischemic acute renal failure by help of single Ig IL-1 receptor-related protein. J. Immunol. 183: 4109-4118.
23. Noris, M., P. Cassis, N. Azzollini, R. Cavinato, D. Cugini, F. Casiraghi, S. Aiello, S. Solini, L. Cassis, M. Mister, et al. 2009. The Toll-IL-1R member Tir8/SIGIRR negatively regulates adaptive immunity against kidney grafts. J. Immunol. 183: 4249-4260.
24. Tamura, T., H. Yanai, D. Savitsky, and T. Taniguchi. 2008. The IRF family transcription factors in immunity and oncogenesis. Annu. Rev. Immunol. 26: 535-584.
25. Shaffer, A. L., N. C. Emre, P. B. Romesser, and L. M. Staudt. 2009. IRF4: Immunity. Malignancy! Therapy? Clin. Cancer Res. 15: 2954-2961.
26. Mittrücker, H. W., T. Matsuyama, A. Grossman, T. M. Kündig, J. Potter, A. Shahinian, A. Wakeham, B. Patterson, P. S. Ohashi, and T. W. Mak. 1997. Requirement for the transcription factor LSIRF/IRF4 for mature B and T lymphocyte function. Science 275: 540-543.
27. Klein, U., S. Casola, G. Cattoretti, Q. Shen, M. Lia, T. Mo, T. Ludwig, K. Rajewsky, and R. Dalla-Favera. 2006. Transcription factor IRF4 controls plasma cell differentiation and class-switch recombination. Nat. Immunol. 7: 773-782.
28. Zheng, Y., A. Chaudhry, A. Kas, P. deRoos, J. M. Kim, T. T. Chu, L. Corcoran, P. Treuting, U. Klein, and A. Y. Rudensky. 2009. Regulatory T-cell suppressor program co-opts transcription factor IRF4 to control T(H)2 responses. Nature 458: 351-356.
29. Brüstle, A., S. Heink, M. Huber, C. Rosenplänter, C. Stadelmann, P. Yu, E. Arpaia, T. W. Mak, T. Kamradt, and M. Lohoff. 2007. The development of inflammatory T(H)-17 cells requires interferon-regulatory factor 4. Nat. Immunol. 8: 958-966.
30. Huber, M., A. Brüstle, K. Reinhard, A. Guralnik, G. Walter, A. Mahiny, E. von Löw, and M. Lohoff. 2008. IRF4 is essential for IL-21-mediated induction, amplification, and stabilization of the Th17 phenotype. Proc. Natl. Acad. Sci. USA 105: 20846-20851.
31. Negishi, H., Y. Ohba, H. Yanai, A. Takaoka, K. Honma, K. Yui, T. Matsuyama, T. Taniguchi, and K. Honda. 2005. Negative regulation of Toll-like-receptor signaling by IRF-4. Proc. Natl. Acad. Sci. USA 102: 15989-15994.
32. Watanabe, T., N. Asano, P. J. Murray, K. Ozato, P. Tailor, I. J. Fuss, A. Kitani, and W. Strober. 2008. Muramyl dipeptide activation of nucleotide-binding oligomerization domain 2 protects mice from experimental colitis. J. Clin. Invest. 118: 545-559.
33. Van Rooijen, N., and A. Sanders. 1994. Liposome mediated depletion of macrophages: mechanism of action, preparation of liposomes and applications. J. Immunol. Methods 174: 83-93.
34. Dong, X., S. Swaminathan, L. A. Bachman, A. J. Croatt, K. A. Nath, and M. D. Griffin. 2007. Resident dendritic cells are the predominant TNF-secreting cell in early renal ischemia-reperfusion injury. Kidney Int. 71: 619-628.
35. Yamada, K., T. Miwa, J. Liu, M. Nangaku, and W. C. Song. 2004. Critical protection from renal ischemia reperfusion injury by CD55 and CD59. J. Immunol. 172: 3869-3875.
36. Lech, M., O. P. Kulkarni, S. Pfeiffer, E. Savarese, A. Krug, C. Garlanda, A. Mantovani, and H. J. Anders. 2008. Tir8/Sigirr prevents murine lupus by suppressing the immunostimulatory effects of lupus autoantigens. J. Exp. Med. 205: 1879-1888.
37. Miura, M., X. Fu, Q. W. Zhang, D. G. Remick, and R. L. Fairchild. 2001. Neutralization of Gro alpha and macrophage inflammatory protein-2 attenuates renal ischemia/reperfusion injury. Am. J. Pathol. 159: 2137-2145.
38. Carreras, E., S. Turner, M. B. Frank, N. Knowlton, J. Osban, M. Centola, C. G. Park, A. Simmons, J. Alberola-Ila, and S. Kovats. 2010. Estrogen receptor signaling promotes dendritic cell differentiation by increasing expression of the transcription factor IRF4. Blood 115: 238-246.
39. Mudter, J., L. Amoussina, M. Schenk, J. Yu, A. Brüstle, B. Weigmann, R. Atreya, S. Wirtz, C. Becker, A. Hoffman, et al. 2008. The transcription factor IFN regulatory factor-4 controls experimental colitis in mice via T cell-derived IL-6. J. Clin. Invest. 118: 2415-2426.
40. Lehtonen, A., V. Veckman, T. Nikula, R. Lahesmaa, L. Kinnunen, S. Matikainen, and I. Julkunen. 2005. Differential expression of IFN regulatory factor 4 gene in human monocyte-derived dendritic cells and macrophages. J. Immunol. 175: 6570-6579. (Pubitemid 41598899)
41. Wang, Y., R. John, J. Chen, J. A. Richardson, J. M. Shelton, M. Bennett, X. J. Zhou, G. T. Nagami, Y. Zhang, Q. Q. Wu, and C. Y. Lu. 2009. IRF-1 promotes inflammation early after ischemic acute kidney injury. J. Am. Soc. Nephrol. 20: 1544-1555.
42. Pulskens, W. P., G. J. Teske, L. M. Butter, J. J. Roelofs, T. van der Poll, S. Florquin, and J. C. Leemans. 2008. Toll-like receptor-4 coordinates the innate immune response of the kidney to renal ischemia/reperfusion injury. PLoS ONE 3: e3596.
43. Feng, Y., H. Zhao, X. Xu, E. S. Buys, M. J. Raher, J. C. Bopassa, H. Thibault, M. Scherrer-Crosbie, U. Schmidt, and W. Chao. 2008. Innate immune adaptor MyD88 mediates neutrophil recruitment and myocardial injury after ischemia-reperfusion in mice. Am. J. Physiol. Heart Circ. Physiol. 295: H1311-H1318.
44. Choi, D. E., J. Y. Jeong, B. J. Lim, K. R. Na, Y. T. Shin, and K. W. Lee. 2009. Pretreatment with the tumor nerosis factor-alpha blocker etanercept attenuated ischemia-reperfusion renal injury. Transplant. Proc. 41: 3590-3596.
45. Linfert, D., T. Chowdhry, and H. Rabb. 2009. Lymphocytes and ischemia-reperfusion injury. Transplant. Rev. (Orlando) 23: 1-10.
46. Jang, H. R., M. T. Gandolfo, G. J. Ko, L. Racusen, and H. Rabb. 2009. The effect of murine anti-thymocyte globulin on experimental kidney warm ischemia-reperfusion injury in mice. Transpl. Immunol. 22: 44-54.